OPMD Natural History Registry Study
Part of Bones, joints & muscles, Brain & nervous system, Digestive system, Ear, nose & throat, Eyes & vision, Genetic & congenital clinical trials.
This study is building a national registry (a database) for people with Oculo-Pharyngeal Muscular Dystrophy (OPMD) in Israel. Joining will help researchers understand how OPMD progresses over time and may lead to better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with OPMD, or have symptoms that might be OPMD (like drooping eyelids, trouble swallowing, or weak throat muscles).
- You are 18 years old or older.
- You are not pregnant.
- You agree to share your medical information for this registry.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the mouth health and saliva of people with OPMD and their household members. By understanding saliva changes, researchers hope to learn more about the disease and find ways to help manage symptoms.
This is a registry that collects health information from adults with neuromyelitis optica spectrum disorder (NMOSD). It aims to better understand NMOSD and support future research, including studies of emerging therapies.
This trial tests an experimental gene therapy (BB-301) for people with OPMD who have trouble swallowing. It involves a one-time injection into the throat muscles during a short surgery, and researchers will check if it is safe and improves swallowing.
This study tracks the natural history of Duchenne Muscular Dystrophy over time. It collects information from patients at four centers to better understand how the disease progresses, which may help improve care in the future.
This study follows people with a genetic form of optic atrophy over time to understand how vision changes. It does not test a treatment but helps doctors learn more about the condition to improve care.
This trial is a registry that collects information from people with fibrodysplasia ossificans progressiva (FOP). It helps researchers better understand the condition and use that knowledge for future studies that could lead to better care.
Hear when a new Oculopharyngeal Muscular Dystrophy (OPMD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.